Article Details
Retrieved on: 2021-08-12 15:11:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
On August 9, 2021, AstraZeneca announced that the European Commission (EC) approved its drug Forxiga (dapagliflozin) in the European Union for ...
Article found on: www.pharmtech.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here